IVF.BK IVF_INSPIRE IVF
- Market cap
- THB 246M
- P/E
- 28.0x
- P/B
- 0.48x
- ROE
- -6.2%
- Dividend yield
- 4.29%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is IVF.BK undervalued?
Graham numberIVF.BK trades 22.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
IVF_INSPIRE IVF fundamental analysis
No fundamental analysis for IVF_INSPIRE IVF yet.
IVF_INSPIRE IVF stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About IVF_INSPIRE IVF
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. It offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. The company provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis,…
Full company profileIVF_INSPIRE IVF financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
IVF_INSPIRE IVF annual financial statements (THB; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 11.2M | 63.3M | 122M | 106M | 61.9M | 55.6M |
| Gross Profit | -2.40M | 31.0M | 79.5M | 61.6M | 19.0M | 11.4M |
| Operating Income | -6.87M | 13.4M | 55.0M | 26.2M | -25.3M | -41.4M |
| EBITDA | - | 14.9M | 66.0M | 41.3M | -3.49M | -21.5M |
| Net Income | -5.14M | 10.1M | 41.0M | 22.2M | -17.4M | -31.7M |
| EPS | -0.01 | 0.02 | 0.09 | 0.05 | -0.04 | -0.07 |
| Balance Sheet | ||||||
| Total Assets | 141M | 152M | 260M | 636M | 599M | 584M |
| Total Liabilities | 95.0M | 95.3M | 82.4M | 78.1M | 70.5M | 71.1M |
| Shareholders' Equity | 46.3M | 56.4M | 177M | 558M | 528M | 512M |
| Cash & Short-term Investments | 360K | 23.0M | 113M | 509M | 467M | 451M |
| Cash Flow | ||||||
| Operating Cash Flow | - | - | 61.4M | 28.1M | -13.9M | -19.2M |
| Capital Expenditure | 0.00 | 0.00 | 281K | 2.45M | 46.0K | 4.16M |
| Free Cash Flow | - | - | 61.2M | 25.7M | -13.9M | -23.3M |
| Ratios | ||||||
| ROE | -11.1% | 17.8% | 23.1% | 4.0% | -3.3% | -6.2% |
| ROA | -3.6% | 6.6% | 15.8% | 3.5% | -2.9% | -5.4% |
| Net Profit Margin | -45.7% | 15.9% | 33.7% | 21.0% | -28.1% | -57.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
IVF_INSPIRE IVF dividends
- Dividend yield
- 4.29%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Mar 13, 2025
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | THB 10.6M | 0.02 | - |
| 2024 | THB 31.0M | 0.07 | 140.0% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns IVF_INSPIRE IVF
- Insiders 70.97%
- Institutions 0.00%
- Public & others 29.03%
- Shares outstanding 440M
- Free float 194M
IVF_INSPIRE IVF company profile
- Company name
- IVF_INSPIRE IVF
- Ticker
- IVF.BK
- Exchange
- Thailand Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Fiscal year end
- December
- Address
- Ploenchit Center Building, Bangkok, Thailand, 10110
- Phone
- 66 2 251 8666
- Website
- inspireivf.com
About IVF_INSPIRE IVF
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. It offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. The company provides obstetrics and gynecology examinations, consulting, and advice, as well as age management medicine, health regeneration, blood dialysis, and blood filtration services. Inspire IVF Public Company Limited was incorporated in 2018 and is based in Bangkok, Thailand.
IVF_INSPIRE IVF management
5- Ms. Kasinee KuldilokeActing COO, CEO & Executive Director · born 1980
- Mr. Parama RattanaubonChief Financial Officer · born 1991
- Mr. Sittideth SangnualChief Scientific Officer & Chief Genetics Laboratory Officer · born 1988
- Mr. Chatree SiribunChief Embryology Laboratory Officer
- Dr. Bancha KanluanChief Medical & Nursing Officer